Semaglutide—a new treatment for obesity-related heart failure with preserved ejection fraction?

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)00653-6/abstract?utm_campaign=conferencealerts&utm_medium=email&dgcid=hubspot_email_conferencealerts_acc24&_hsenc=p2ANqtz--i13scrpQ5tzFskYZQs_epq4yCG7dGEZtq0q6BbcCME2QvSrbiddh2mr4xZdvIP6Qhr8JT7btj4ImcVi_OjmhUDCvzEQ&_hsmi=301365793&utm_content=301365793&utm_source=hs_email